Genzyme Fights Dismissal Of D&O Policy Suit

Law360, New York (October 29, 2009, 3:09 PM EDT) -- Genzyme Corp. is challenging the dismissal of its suit against Federal Insurance Co. that called for the insurer to pick up the tab for a securities class action the biotechnology company settled with investors two years ago.

Massachusetts-based Genzyme filed a notice of appeal to the U.S. Court of Appeals for the First Circuit on Wednesday, a month after the U.S. District Court for the District of Massachusetts granted Federal Insurance's motion to toss the case.

Genzyme alleged in its suit that a directors and officers...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.